Outcomes of Mechanical Thrombectomy With the FlowTriever Device in Acute Pulmonary Embolism, Results of a Swedish Retrospective Analysis

Status: Completed
Location: See location...
Intervention Type: Drug, Device
Study Type: Observational
SUMMARY

International guidelines recommend intravenous thrombolysis (IVT) for high-risk pulmonary embolism (PE). In high-risk PE where IVT is contraindicated or has failed, surgical embolectomy or catheter-directed intervention (CDI) is recommended. CDI is also recommended as an alternative in patients with intermediate-risk PE with haemodynamic deterioration during anticoagulation treatment. Although there is a lack of randomized studies comparing CDI to anticoagulation or systemic thrombolysis in PE, several studies and recent meta-analyses have shown that CDI is an effective treatment that is associated with fewer complications than IVT, especially bleeding.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years

• Acute PE verified by computed tomography (CT) or angiography

• PE treated with thrombolysis or FlowTriever® during the time period from January 1st of the year when FlowTriever was introduced at each respective participating center to the end of 2023.

Locations
Other Locations
Sweden
Sahlgrenska University Hospital
Gothenburg
Time Frame
Start Date: 2023-04-01
Completion Date: 2025-03-31
Participants
Target number of participants: 132
Treatments
FlowTriever
Acute PE patients treated with the FlowTriever device
Intravenous Thrombolysis
Acute PE patients treated with intravenous thrombolysis
Sponsors
Collaborators: Sunderby Hospital, Stockholm South General Hospital, Karolinska University Hospital, University Hospital, Linkoeping, Danderyd Hospital
Leads: Kristina Svennerholm

This content was sourced from clinicaltrials.gov